Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|May 10, 2019
Antimicrobial Peptide LL-37 Facilitates Intracellular Uptake of RNA Aptamer Apt 21-2 Without Inducing an Inflammatory or Interferon ResponseTom Macleod, Joseph Ward, Adewonuola A Alase, et al.
Expert Review of Vaccines|December 12, 2018
HPV vaccines and lupus: current approaches towards preventing adverse immune cross-reactivityNicola L Bragazzi, Charlie Bridgewood, Kassem Sharif, et al.
The Israel Medical Association Journal : IMAJ|June 20, 2020
Rationale for Evaluating PDE4 Inhibition for Mitigating against Severe Inflammation in COVID-19 Pneumonia and BeyondCharlie Bridgewood, Giovanni Damiani, Kassem Sharif, et al.
Clinical Rheumatology|April 3, 2020
Patients with psoriatic arthritis have higher levels of FeNO than those with only psoriasis, which may reflect a higher prevalence of a subclinical respiratory involvementGiovanni Damiani, Alessia Pacifico, Maurizio Rizzi, et al.
Frontiers in Immunology|March 15, 2018
IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates AngiogenesisCharlie Bridgewood, Gareth W Fearnley, Anna Berekmeri, et al.
Nutrients|January 30, 2019
The Impact of Ramadan Fasting on the Reduction of PASI Score, in Moderate-To-Severe Psoriatic Patients: A Real-Life Multicenter StudyGiovanni Damiani, Abdulla Watad, Charlie Bridgewood, et al.
Archives of Medical Science : AMS|April 7, 2025
Familial Mediterranean fever association with schizophrenia: insights from big data analysisKassem Sharif, Abdulla Watad, Nicola Luigi Bragazzi, et al.
Clinical Immunology (Orlando, Fla.)|August 31, 2019
The novel cytokine Metrnl/IL-41 is elevated in Psoriatic Arthritis synovium and inducible from both entheseal and synovial fibroblastsCharlie Bridgewood, Tobias Russell, Helen Weedon, et al.
Rheumatology (Oxford, England)|November 30, 2020
Regulation of entheseal IL-23 expression by IL-4 and IL-13 as an explanation for arthropathy development under dupilumab therapyCharlie Bridgewood, Kassem Sharif, Jane Freeston, et al.
The Journal of Investigative Dermatology|April 8, 2022
T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17‒Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune DiseasesCharlie Bridgewood, Miriam Wittmann, Tom Macleod, et al.
Pageof 5